Evidence map›Paper›PMID 32051246›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects.

Zhihua Jiao, Huaqing Cai, Yu Long, Orit Katarina Sirka, Veena Padmanaban, Andrew J Ewald, Peter N Devreotes

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Zhihua JiaoDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
Huaqing CaiNational Laboratory of Biomacromolecules, Chinese Academy of Sciences Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China huaqingcai@ibp.ac.cn pnd@jhmi.edu.
Yu LongDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
Orit Katarina SirkaDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
Veena PadmanabanDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
Andrew J EwaldDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
Peter N DevreotesDepartment of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205; huaqingcai@ibp.ac.cn pnd@jhmi.edu.
Johns Hopkins University · USChinese Academy of Sciences · CN

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Excitable Networks in Directed Cell MigrationR35GM118177 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Peter N Devreotes · 2016 to 2026
$12.1M
The Role of Physical Cues in Collective Cell InvasionU54CA210173 · NCI · JOHNS HOPKINS UNIVERSITY · PI PIENTA, KENNETH J., WIRTZ, DENIS · 2016 to 2020
$9.9M
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer MetastasesU01CA217846 · NCI · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S., EWALD, ANDREW JOSEF · 2017 to 2021
$4.8M
Zeiss LSM780 Confocal Microscope for a Core FacilityS10OD016374 · OD · JOHNS HOPKINS UNIVERSITY · PI KUO, SCOT CHARLES · 2013 to 2013
$584k
NCI NIH HHS P30 CA006973NCI NIH HHS U01 CA217846NCI NIH HHS U54 CA210173NIGMS NIH HHS R35 GM118177NIH HHS S10 OD016374
6 · The paper itself

Abstract

Cancer cells display novel characteristics which can be exploited for therapeutic advantage. Isolated studies have shown that 1) the mevalonate pathway and 2) increased macropinocytosis are important in tumorigenesis, but a connection between these two observations has not been envisioned. A library screen for compounds that selectively killed

Indexed as

AnimalsCell LineDictyosteliumHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic AcidMiceOncogenesOrganoidsPinocytosisQuinolinesHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic AcidpitavastatinQuinolinescancerchemotaxismevalonate pathwaysmall GTPasestumor organoids

Identifiers

PMID32051246
PMCPMC7049144
OpenAlexW3006554079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.